09-17 Pulsenmore Expands Fertility Platform into the United Kingdom and Northern Ireland CI
09-09 Pulsenmore Expands into Fertility Care: Completes CE European Registration of Home Ultrasound System for Follicular Monitoring AQ
09-08 Pulsenmore Completes CE European Registration Of Home Ultrasound System For Follicular Monitoring CI
08-31 Pulsenmore Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 CI
08-19 Pulsenmore Ltd. announces the expansion of its activities in Israel CI
08-18 Pulsenmore Receives Second AI Grant Within One Month: Israel Innovation Authority Approves $1.27 Million for SmartScan AI Program AQ
08-17 Pulsenmore Ltd Receives Israel Innovation Authority Grant Of USD 1.27 Million For Smartscan AI Program CI
07-13 Pulsenmore Selected For Israel Innovation Authority And Ministry Of Health Program To Lead $1 Million AI Development Project CI
07-02 Pulsenmore Files Resale Registration for 3.1 Million Shares MT
06-26 Pulsenmore Ltd. announced that it has received $7.499844 million in funding CI
06-25 Pulsenmore to Raise $7.5 Million in Equity Private Placement MT
06-24 Pulsenmore Ltd. announced that it expects to receive $7.499844 million in funding CI
06-24 Top Midday Gainers MT
06-24 Pulsenmore Enters Partnership with Ouma Health for its Home Ultrasound Platform; Shares Rise Pre-Bell MT
06-24 Pulsenmore Ltd. And Ouma Health Enter Strategic Partnership To Expand Access To Remote Prenatal Care Across The United States CI
03-30 Pulsenmore : Corporate Presentation (Pulsenmore Investor Deck 03302026 ) PU
03-30 Pulsenmore Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
03-18 Pulsenmore : Announces Full Year 2025 Earnings Conference Call PU
02-09 Pulsenmore Ltd. Enters Commercial Engagement With TLC Perinatal For Home Ultrasound Services In U.S CI
02-02 Pulsenmore Ltd. Announces First Commercial Engagement with a Leading U.S. Based Medical Center CI
01-26 Pulsenmore Ltd. and Clalit Health Services Launch First At-Home Follicular Monitoring Service for IVF and Fertility Preservation CI
01-21 Pulsenmore Ltd.(NasdaqCM:PLSM) added to NASDAQ Composite Index CI
01-20 Pulsenmore Ltd. will Change its Ticker to PLSM from PULS CI
11-03 Pulsenmore Ltd. Receives FDA De Novo Marketing Authorization for Home-Use Prenatal Ultrasound, Pioneering a New Era of Prenatal Care in the U.S CI
11-03 Pulsenmore Receives FDA De Novo Marketing Authorization for Home-Use Prenatal Ultrasound, Pioneering a New Era of Prenatal Care in the U.S. PR
No results match your criteria
  1. Stock Market
  2. Stocks
  3. PLSM Stock
  4. News Pulsenmore Ltd.